Alfonso J. Rodriguez-Morales

Fundación Universitaria Autónoma De Las Américas

Senior Researcher and Faculty, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia. Researcher and Faculty, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. Non-Resident Faculty Researcher, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon. Dr. Rodriguez-Morales is an expert in tropical and emerging diseases, particularly in zoonotic and vector-borne diseases, including COVID-19 and mpox, and their occurrence among travelers and migrants, as well as its approach under the One Health lens. President, Latin American Society for Travel Medicine (SLAMVI) (2023-2025). Past-President, Colombian Association of Infectious Diseases (ACIN) (2021-2023). Member, Committee on Tropical Medicine, Zoonoses, and Travel Medicine, ACIN. Member of the Council, International Society for Infectious Diseases (ISID) (2020-2026). Editor-in-Chief, Travel Medicine and Infectious Diseases. Full Member of European Society for Clinical Microbiology and Infectious Diseases (ESCMID). Member of the American Society for Tropical Medicine & Hygiene (ASTM&H). Member of the International Society for Travel Medicine (ISTM). He was member of the Technical Working Group of the World Health Organization (WHO) for the Global Research Agenda on Health and Migration and the 3rd Global Consultation on the Health of Migrants and Refugees (co-organized by WHO, UNHCR and IOM) (2023). Currently, Member, World Health Organization (WHO) Guideline Development Group for Clinical Management of post COVID-19 condition (2024). H index 64 (Scopus).

Alfonso J. Rodriguez-Morales

13books edited

11chapters authored

Latest work with IntechOpen by Alfonso J. Rodriguez-Morales

Zoonoses, diseases transmitted from animals to humans, hold immense global significance, impacting public health, economies, and ecosystems. Adopting the One Health approach, which recognizes the interconnectedness of human, animal, and environmental health, is crucial in tackling these challenges. Zoonotic diseases pose significant public health threats. Diseases like rabies, Ebola, and influenza have claimed countless lives worldwide. Without proper management, these diseases can rapidly escalate into pandemics, as seen with the COVID-19 pandemic, originating from a zoonotic transmission. The health of humans and animals are intricately linked, making collaborative efforts essential for disease prevention and control. Zoonoses have profound economic implications. Outbreaks can devastate agricultural sectors, leading to loss of livestock, reduced productivity, and trade restrictions. For instance, the 2001 foot-and-mouth disease outbreak in the United Kingdom resulted in billions of dollars in economic losses. Addressing zoonoses through a One Health approach can safeguard livelihoods and ensure food security. Furthermore, zoonotic diseases impact biodiversity and ecosystems. Diseases like West Nile virus and Lyme disease can affect wildlife populations, disrupting ecosystems and biodiversity. Additionally, habitat destruction and wildlife trafficking increase the likelihood of zoonotic spillover events. We can mitigate these risks and preserve ecosystem integrity through conservation efforts and sustainable land-use practices. The global importance of zoonoses cannot be overstated. By embracing the One Health approach, we can address these complex challenges comprehensively. Collaboration between human and veterinary medicine, environmental science, and other disciplines is essential for effective disease surveillance, prevention, and control. By prioritizing the health of people, animals, and the environment, we can build a safer, healthier future for all.

Go to the book